{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T09:38:02Z","timestamp":1790329082742,"version":"4.1.0"},"reference-count":27,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2013,4,28]],"date-time":"2013-04-28T00:00:00Z","timestamp":1367107200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Evidence favoring a critical role for mast cells (<jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content>) in cutaneous malignancies is conflicting.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using the immunohistochemical stain tryptase, <jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content> counts were performed in the following tumor categories: epithelial (basal cell carcinoma [<jats:styled-content style=\"fixed-case\">BCC<\/jats:styled-content>]: nodular [<jats:styled-content style=\"fixed-case\">N<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a010, infiltrative [I], <jats:italic>n<\/jats:italic>\u00a0=\u00a010; squamous cell carcinoma [<jats:styled-content style=\"fixed-case\">SCC<\/jats:styled-content>]: well differentiated [<jats:styled-content style=\"fixed-case\">W<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a09, moderate\/poorly differentiated [<jats:styled-content style=\"fixed-case\">MP<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a015); melanocytic (intradermal nevus, <jats:italic>n<\/jats:italic>\u00a0=\u00a010, malignant melanoma <jats:italic>in situ<\/jats:italic> [<jats:styled-content style=\"fixed-case\">MMIS<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a08, invasive melanoma, <jats:italic>n<\/jats:italic>\u00a0=\u00a015); vascular (hemangioma [<jats:styled-content style=\"fixed-case\">HEM<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a011, <jats:styled-content style=\"fixed-case\">K<\/jats:styled-content>aposi's sarcoma [<jats:styled-content style=\"fixed-case\">KS<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a014, angiosarcoma [<jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content>] <jats:italic>n<\/jats:italic>\u00a0=\u00a08); and fibrohistiocytic (dermatofibroma [<jats:styled-content style=\"fixed-case\">DF<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a07, atypical fibroxanthoma [<jats:styled-content style=\"fixed-case\">AFX<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a05, dermatofibrosarcoma protuberans [<jats:styled-content style=\"fixed-case\">DFSP<\/jats:styled-content>], <jats:italic>n<\/jats:italic>\u00a0=\u00a05). <jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content> (intra\u2010 and peritumoral) were expressed as cells per 10 high\u2010power fields.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean <jats:styled-content style=\"fixed-case\">MC<\/jats:styled-content> counts were: <jats:styled-content style=\"fixed-case\">BCCN<\/jats:styled-content> 166.30; <jats:styled-content style=\"fixed-case\">BCCI<\/jats:styled-content> 130; <jats:styled-content style=\"fixed-case\">SCCW<\/jats:styled-content> 167.22; <jats:styled-content style=\"fixed-case\">SCCMP<\/jats:styled-content> 133.80; nevus 156.40; <jats:styled-content style=\"fixed-case\">MMIS<\/jats:styled-content> 93; <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> radial growth phase 73.86; <jats:styled-content style=\"fixed-case\">MM<\/jats:styled-content> vertical growth phase 82.13; <jats:styled-content style=\"fixed-case\">HEM<\/jats:styled-content> 165.18; <jats:styled-content style=\"fixed-case\">KS<\/jats:styled-content> 120.57; <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> 168.13; <jats:styled-content style=\"fixed-case\">DF<\/jats:styled-content> 247.86; <jats:styled-content style=\"fixed-case\">AFX<\/jats:styled-content> 280.20; and <jats:styled-content style=\"fixed-case\">DFSP<\/jats:styled-content> 83.60. Using a one\u2010way analysis of variance, statistically significant differences were observed in the following pairs: <jats:styled-content style=\"fixed-case\">AFX<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">DF<\/jats:styled-content> vs. <jats:styled-content style=\"fixed-case\">DFSP<\/jats:styled-content>, nevus vs. melanoma, <jats:styled-content style=\"fixed-case\">AS<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">HEM<\/jats:styled-content> vs. <jats:styled-content style=\"fixed-case\">KS<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our findings appear to point towards a dichotomous role for mast cells in fibrohistiocytic and vascular neoplasms and argue against their preferential recruitment in epithelial malignancies and malignant melanoma. The value of mast cell counts as a prognostic index appears to be limited in most cutaneous malignancies.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1365-4632.2012.05745.x","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T04:02:52Z","timestamp":1367208172000},"page":"806-811","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Mast cells in cutaneous tumors: innocent bystander or maestro conductor?"],"prefix":"10.1111","volume":"53","author":[{"given":"Asok","family":"Biswas","sequence":"first","affiliation":[{"name":"Department of Pathology Western General Hospital Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna E.","family":"Richards","sequence":"additional","affiliation":[{"name":"Dermatopathology Section Department of Dermatology Boston University School of Medicine Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Massaro","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Boston University School of Medicine Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Mahalingam","sequence":"additional","affiliation":[{"name":"Dermatopathology Section Department of Dermatology Boston University School of Medicine Boston MA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800474"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.2009.01414.x"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e31815c932a"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/path.1711620204"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2004.017210"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2001.tb00139.x"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2340\/00015555662934","article-title":"Skin tumors and reactive cellular infiltrate: further studies","volume":"66","author":"Claudatus JC","year":"1986","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800094"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01613134"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2010.03635.x"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.3109\/00016357.2010.494622"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2006.038885"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-200009010-00001"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2002.tb00264.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.101883"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1998.tb01683.x"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/hupa.2000.16658"},{"key":"e_1_2_6_19_1","first-page":"419","article-title":"Role of mast cells in dermatofibroma: recent viewpoints into the pathogenesis","volume":"13","author":"Yamamoto T","year":"2003","journal-title":"Eur J Dermatol"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/DAD.0b013e31817fd3a4"},{"key":"e_1_2_6_21_1","first-page":"11","article-title":"Ultraviolet induced p53 mutations in atypical fibroxanthoma","volume":"145","author":"Dei Tos AP","year":"1994","journal-title":"Am J Pathol"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00050.x"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05966.x"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4725.2000.09207.x"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1986.198"},{"key":"e_1_2_6_26_1","first-page":"177","article-title":"bFGF as an autocrine growth factor for human melanoma","volume":"3","author":"Halaban R","year":"1988","journal-title":"Oncogene Res"},{"key":"e_1_2_6_27_1","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.4049\/jimmunol.151.5.2667","article-title":"IL\u20108 produced by malignant melanoma cells in vitro is an essential autocrine growth factor","volume":"151","author":"Schadendorf D","year":"1993","journal-title":"J Immunol"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2004.02.013"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2012.05745.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2012.05745.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T03:12:20Z","timestamp":1696302740000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2012.05745.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,28]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1111\/j.1365-4632.2012.05745.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2012.05745.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,28]]},"assertion":[{"value":"2013-04-28","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}